Skip to content

The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy

A Prospective Randomized Double-blinded Clinical Trial About the Efficacy of Oral Limaprost Administration Following Surgery for Cervical Myelopathy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02125981
Enrollment
160
Registered
2014-04-29
Start date
2014-09-01
Completion date
2023-04-01
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Myelopathy

Keywords

limaprost alfadex, cervical myelopathy, surgery

Brief summary

The limaprost alfadex can improve the surgical outcomes in patients with cervical myelopathy.

Interventions

taking Limaprost α-Cyclodextrin Clathrate 1 Tablets (166.67 μg), three times per day

DRUGPlacebo

taking placebo drug

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Older than 20 years old * Compressive cervical myelopathy, confirmed by MRI, including C1-C2 instability, ossification of posterior longitudinal ligament * Plan to undergo cervical surgery for myelopathy * JOA score less than 15 points * Signed informed consent of patient or legal guardian

Exclusion criteria

* Infection or malignancy * Taking Limaprost before surgery * Pregnancy or expected to be pregnant or breast feeding * severe cardiovascular, pulmonary, renal disease or distress, brain pathology * any related coagulopathy * any drug to cause bleeding tendency * severe pain from other disease * any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study * patient cannot follow study protocol, for any reason

Design outcomes

Primary

MeasureTime frameDescription
Japanese Orthopedic Association (JOA) recovery ratesup to 12 months after operationJOA recovery rate = \[(postoperative JOA score) - (preoperative JOA score)\] / \[(17-(preoperative JOA score)\] x 100 (%).

Secondary

MeasureTime frameDescription
Neck disability index scoreup to 12 months after operation
Japanese orthopaedic association Cervical Myelopathy Evaluation Questionnaire scoreup to 12 months after operation
Visual Analog Pain Scale for neck painup to 12 months after operation
Japanese orthopaedic association scoreup to 12 months after surgery
assessment of the efficacy of positron emission tomography (PET)up to 12 months after operationThe assessment of the efficacy of PET for prediction of drug (Limaprost) effect
Questionnaire Short Form 12up to 12 months after operation

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026